Carried to safety
Cytocell, a biotech firm from Oxfordshire, UK, has developed a simple, safe and reliable test that uses foetal blood cells that leak through the placenta into the mother's circulation, to detect genetic abnormalities. The technique may eventually replace amniocentesis, which presents a one-in-200 chance of a miscarriage.
But the test only makes use of samples obtained from after 16 weeks of pregnancy, and the foetal cells have to be cultured for three weeks. Cytocell is coming up with another technique called 'fluorescence in situ hybridisation' that could provide faster results.
Related Content
- Plastic Waste Management (Amendment) Rules, 2024
- Affidavit on behalf of Deputy Commissioner, South Garo Hills district, Baghmara on a stone quarry in Budugre, 03/03/2024
- Order of the Supreme Court of India regarding mining of magnesite/dolomite by N B Minerals Corporation Limited, Didihat, Pithoragarh district, Uttarakhand, 27/02/2024
- Guidelines for drinking-water quality: small water supplies
- Judgment of the Kerala High Court regarding unauthorized hawkers/sellers of articles including plastic toys, plastic articles and drinking water in PET bottles in Sannidhanam, Pamba and Nilakkal, Sabarimala, Kerala, 08/01/2024
- Judgment of the National Green Tribunal regarding encroachment of land, Saket, Delhi, 20/12/2023